Tennessee Center for Clinical Trials Report issue

For profit Phase 2
Founded: Tullahoma TN United States (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2007
NCT00454818
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Tennessee Center for Clinical Trials, Harton Regional Medical Center

Active Ingredients

Drugs in Phase 2 Trials (1)

mydicar (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiomyopathies (Phase 2)

Cardiomyopathy, Dilated (Phase 2)

Heart Failure (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1